These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 20156489

  • 21. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.
    Neurosci Lett; 2011 Oct 17; 504(1):35-9. PubMed ID: 21907264
    [Abstract] [Full Text] [Related]

  • 22. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.
    Neuroscience; 2010 Jun 02; 167(4):1183-91. PubMed ID: 20211696
    [Abstract] [Full Text] [Related]

  • 23. The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.
    Tamburella A, Micale V, Mazzola C, Salomone S, Drago F.
    Eur J Pharmacol; 2012 May 15; 683(1-3):148-54. PubMed ID: 22426162
    [Abstract] [Full Text] [Related]

  • 24. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR.
    Aust N Z J Psychiatry; 2007 Mar 15; 41(3):222-30. PubMed ID: 17464703
    [Abstract] [Full Text] [Related]

  • 25. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
    Prescrire Int; 2010 Feb 15; 19(105):5-8. PubMed ID: 20455329
    [Abstract] [Full Text] [Related]

  • 26. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
    Paterson NE, Ricciardi J, Wetzler C, Hanania T.
    Neurosci Res; 2011 Jan 15; 69(1):41-50. PubMed ID: 20934466
    [Abstract] [Full Text] [Related]

  • 27. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB.
    Child Adolesc Psychiatr Clin N Am; 2006 Jan 15; 15(1):13-50. PubMed ID: 16321724
    [Abstract] [Full Text] [Related]

  • 28. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
    Easton N, Steward C, Marshall F, Fone K, Marsden C.
    Neuropharmacology; 2007 Feb 15; 52(2):405-14. PubMed ID: 17020775
    [Abstract] [Full Text] [Related]

  • 29. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ, Cheetham SC, Smith SL.
    Neuropharmacology; 2009 Dec 15; 57(7-8):608-18. PubMed ID: 19761781
    [Abstract] [Full Text] [Related]

  • 30. Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate.
    Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA.
    Pharmacol Res; 2010 Dec 15; 62(6):523-9. PubMed ID: 20691787
    [Abstract] [Full Text] [Related]

  • 31. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A.
    Behav Brain Res; 2006 Feb 28; 167(2):379-82. PubMed ID: 16246436
    [Abstract] [Full Text] [Related]

  • 32. Dimensional analysis of ADHD subtypes in rats.
    Blondeau C, Dellu-Hagedorn F.
    Biol Psychiatry; 2007 Jun 15; 61(12):1340-50. PubMed ID: 17054922
    [Abstract] [Full Text] [Related]

  • 33. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
    Umehara M, Ago Y, Fujita K, Hiramatsu N, Takuma K, Matsuda T.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):250-7. PubMed ID: 23376565
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.
    Health Technol Assess; 2009 Oct 28; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [Abstract] [Full Text] [Related]

  • 38. Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine.
    Lempp T, Toennes SW, Wunder C, Russe OQ, Möser CV, Kynast KL, Freitag CM, Niederberger E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan 10; 40():221-8. PubMed ID: 22960082
    [Abstract] [Full Text] [Related]

  • 39. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
    Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH.
    J Child Psychol Psychiatry; 2015 Jan 10; 56(1):40-8. PubMed ID: 24942409
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.